BPC-157 + TB-500 (Tβ4 Frag) (blend) 5+5mg

One vial with nominal amounts of BPC-157 5 mg and Thymosin Beta 4 fragment 5 mg. Lot 26-0038: measured contents 4.72 mg and 4.65 mg respectively, 5.6% and 7.0% below nominal. These are separate component results, not a combined content or purity result. The laboratory confirmed a Thymosin Beta 4 fragment for lot 26-0038. The exact sequence, terminal modifications, molecular formula, molecular weight and CAS number are not yet established in the available documentation. The fragment name does not establish residues 17–23 or acetylation.

Online ordering is available for this product through the purchase area. Delivery covers supported EU destinations, with territorial exclusions. Published terms: Standard €8.90 (2–5 business days from dispatch), Express €29.90 (1–3); Standard free from €200 after discounts. Times are estimates. The entered address determines eligible options and the final total at checkout, not the site language.

Compare the lot number and label details with the documents published for that lot. The report describes the result for the analysed sample; it does not mean that every vial has been tested individually. The product image illustrates the corrected wording “TB-500 (Tβ4 Frag)”. The original COA photograph is unchanged and retains the earlier label. The image does not confirm that physical vials have been relabelled.